Literature DB >> 8784808

Application of in vitro Myo-differentiation of non-muscle cells to enhance gene expression and facilitate analysis of muscle proteins.

P A Roest1, A C van der Tuijn, H B Ginjaar, R C Hoeben, F B Hoger-Vorst, E Bakker, J T den Dunnen, G J van Ommen.   

Abstract

Introduction of the myogenic-determination gene MyoD forces non-muscle cell cultures into myogenesis, thereby inducing expression of muscle-specific proteins and facilitating their analysis. In several MyoD-transfected fibroblasts, immunohistochemical detection showed expression of desmin after three days, of titin after five days and of dystrophin after seven days. Cell fusion (myotube formation) could be observed after five days. After nine days a fraction of the cells showed a striated titin pattern, indicating an advanced state of muscle differentiation. Dystrophin (the protein absent in Duchenne Muscular Dystrophy patients) can be detected in MyoD-transfected and differentiated fibroblasts from healthy individuals, and is absent in those of patients. MyoD-transfection increases transcription of the dystrophin gene, facilitating RNA-based mutation detection. Using RNA from MyoD-transfected, differentiated fibroblasts of a deceased patient with an unknown, non-deletion mutation, we were able to identify a CGA-->TGA nonsense mutation in the rod domain at basepair 6492 and to establish a rapid mutation specific test for future diagnosis of the mutation in his relatives.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784808     DOI: 10.1016/0960-8966(96)00006-5

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

1.  Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease.

Authors:  M J E Havenga; A A C Lemckert; O J A E Ophorst; M van Meijer; W T V Germeraad; J Grimbergen; M A van Den Doel; R Vogels; J van Deutekom; A A M Janson; J D de Bruijn; F Uytdehaag; P H A Quax; T Logtenberg; M Mehtali; A Bout
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes.

Authors:  Manuel A F V Gonçalves; Josephine M Janssen; Quynh G Nguyen; Takis Athanasopoulos; Stephen D Hauschka; George Dickson; Antoine A F de Vries
Journal:  Mol Ther       Date:  2011-01-25       Impact factor: 11.454

3.  The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol.

Authors:  A J van Essen; A L Kneppers; A H van der Hout; H Scheffer; I B Ginjaar; L P ten Kate; G J van Ommen; C H Buys; E Bakker
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

4.  Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense.

Authors:  Annemieke Aartsma-Rus; Anneke A M Janson; Wendy E Kaman; Mattie Bremmer-Bout; Gert-Jan B van Ommen; Johan T den Dunnen; Judith C T van Deutekom
Journal:  Am J Hum Genet       Date:  2003-12-16       Impact factor: 11.025

5.  A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies.

Authors:  Matteo Bovolenta; Marcella Neri; Sergio Fini; Marina Fabris; Cecilia Trabanelli; Anna Venturoli; Elena Martoni; Elena Bassi; Pietro Spitali; Simona Brioschi; Maria S Falzarano; Paola Rimessi; Roberto Ciccone; Emma Ashton; Joanne McCauley; Shu Yau; Stephen Abbs; Francesco Muntoni; Luciano Merlini; Francesca Gualandi; Alessandra Ferlini
Journal:  BMC Genomics       Date:  2008-11-28       Impact factor: 3.969

6.  Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.

Authors:  Maria Kinali; Virginia Arechavala-Gomeza; Lucy Feng; Sebahattin Cirak; David Hunt; Carl Adkin; Michela Guglieri; Emma Ashton; Stephen Abbs; Petros Nihoyannopoulos; Maria Elena Garralda; Mary Rutherford; Caroline McCulley; Linda Popplewell; Ian R Graham; George Dickson; Matthew J A Wood; Dominic J Wells; Steve D Wilton; Ryszard Kole; Volker Straub; Kate Bushby; Caroline Sewry; Jennifer E Morgan; Francesco Muntoni
Journal:  Lancet Neurol       Date:  2009-08-25       Impact factor: 44.182

7.  Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.

Authors:  Annemieke Aartsma-Rus; Anneke A M Janson; Gert-Jan B van Ommen; Judith C T van Deutekom
Journal:  BMC Med Genet       Date:  2007-07-05       Impact factor: 2.103

8.  Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening.

Authors:  Patricia Soblechero-Martín; Edurne Albiasu-Arteta; Aina Anton-Martinez; Laura de la Puente-Ovejero; Iker Garcia-Jimenez; Gabriela González-Iglesias; Irene Larrañaga-Aiestaran; Andrea López-Martínez; Javier Poyatos-García; Estíbaliz Ruiz-Del-Yerro; Federico Gonzalez; Virginia Arechavala-Gomeza
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.